Executive Research Companion

Chi-Square Intelligence for Healthcare Operations

From categorical counts to accountable decisions: a leadership framework for detecting, diagnosing, and acting on operational variation in access, quality, imaging, revenue cycle, and workforce data.

3Test designs
7Data readiness controls
3Worked healthcare cases
6Stage operating cycle
22Peer-reviewed sources

Leadership Conclusion

The chi-square test is most valuable when a healthcare leader must determine whether an observed distribution of categorical events differs from a plan, whether two categorical variables are associated, or whether operational patterns vary across sites. Its value is not just the p-value. Decision quality depends on validated categories, independent observations, adequate expected counts, effect size, residual analysis, and a clinically or operationally meaningful response.

Healthcare operations generate categorical data continuously: attended or missed appointments, completed or incomplete examinations, accepted or denied claims, event classifications, discharge destinations, compliance status, and reason codes. Chi-square methods convert these counts into a formal test of whether observed differences are compatible with chance variation under a defined null model. The test answers a narrow but consequential question. It does not identify causation, adjust for confounding, measure economic value, or prove clinical importance. A statistically significant result should open an operational investigation rather than close one.

The three-part executive reading rule

1

Detect

Use the omnibus chi-square statistic to determine whether the full categorical pattern is inconsistent with the null model.

2

Diagnose

Compare observed and expected counts, then inspect adjusted residuals to identify the categories and cells driving the result.

3

Decide

Pair effect size and absolute differences with patient impact, cost, feasibility, equity, and balancing measures before authorizing change.

Six conclusions for healthcare leaders

01

Start with the decision, not the software

Define the operational question, target population, categories, denominator, comparison basis, and action threshold before calculating a statistic.

02

Select the correct chi-square design

Goodness-of-fit compares an observed distribution with a specified expectation. Independence tests association between two categorical variables in one population. Homogeneity compares a distribution across independent groups.

03

Treat data structure as a governance issue

Duplicate encounters, repeated measures, unstable reason codes, and missing categories can invalidate the analysis even when the computation is technically correct.

04

Report more than statistical significance

A decision-ready result includes counts, percentages, expected counts, chi-square, degrees of freedom, p-value, effect size, residuals, and operational interpretation.

05

Escalate when the question is more complex

Use Fisher’s exact test for sparse, small tables; McNemar’s test for paired binary outcomes; regression for adjusted analysis; and longitudinal or clustered methods when independence is violated.

06

Link findings to intervention and re-measurement

The analysis should specify the process owner, targeted cells, intervention, balancing measures, and post-change monitoring period.

Where the leadership questions live

Healthcare leadership questionPrimary testExample categorical outcomeDecision use
Does demand match the staffing plan?Goodness of fitCT volume by shiftRebalance coverage or scheduling templates
Is access associated with scheduling lead time?IndependenceCompleted vs missed appointmentTarget reminders, navigation, or slot release
Do denial patterns differ by hospital?HomogeneityDenial reason categoryAssign site-specific revenue-cycle countermeasures
Did an intervention change a paired binary outcome?Not ordinary chi-squareSame unit before vs afterUse McNemar or a repeated-measures model

Executive Lens

Chi-square is a detector and localizer of categorical variation, not a causal model. A credible analysis should identify what differs, where it differs, how much it differs, and what operational hypothesis should be tested next.

The statistical foundation

Observed counts are the actual numbers in the contingency table. Expected counts are generated from the null hypothesis. Squaring prevents positive and negative differences from canceling, while dividing by the expected count scales the discrepancy. The sum is compared with a chi-square reference distribution whose shape depends on the degrees of freedom.

The core statistic

χ² = Σ (O − E)² / E

Each cell contributes a nonnegative amount. Larger discrepancies, especially where the expected count is small, contribute more strongly to the total.

Expected counts

Eij = (row total × column total) / N

For independence and homogeneity, expected counts represent the table anticipated if row and column classifications were unrelated.

Degrees of freedom

df = k − 1  ·  df = (r − 1)(c − 1)

Goodness-of-fit uses k fixed categories. An r by c contingency table uses cell information remaining after marginal constraints.

What the p-value actually is

critical value (df = 3, α = .05)p-value: right-tail areachi-square statistic →

The shaded area represents results at least as discrepant as the critical value. The p-value is not the probability that the null hypothesis is true.

A small p-value indicates that the observed table would be unusual if the null model and test assumptions were correct. It does not measure effect magnitude, decision value, or the probability of replication. The American Statistical Association and subsequent methodological guidance caution against using a single threshold as a binary decision rule (Greenland et al., 2016; Wasserstein & Lazar, 2016).

The inferential boundary

The test can support

  • Evidence that an observed distribution differs from a specified expectation
  • Evidence of association between categorical variables
  • Evidence that group distributions are not homogeneous
  • A global comparison across all table cells

Not established without additional analysis

  • The clinical, financial, or operational importance of the difference
  • Causation, or the mechanism producing the association
  • Which cell differences are responsible, unless residuals or follow-up comparisons are examined
  • Adjustment for age, acuity, payer mix, site clustering, repeated encounters, or other confounders

Methodological Position

The report treats the chi-square test as an inferential component within an operational decision-making system. It rejects three common shortcuts: equating p < .05 with importance, inferring causation from association, and treating a large sample as a substitute for sound category design.

Interactive design selector

Selection begins with the sampling design and the operational question. Independence and homogeneity use the same general computation, but their interpretations differ. Choose the statement that matches your situation.

From the dashboard difference to the inferential question

Dashboard observationNull hypothesisChi-square questionLeadership response if evidence is credible
Evening CT volume appears above planDemand follows the planned shift distributionGoodness of fitValidate acuity and arrival drivers, then adjust staffing or protocols
Long-lead appointments appear more likely to be missedAttendance is independent of lead-time categoryIndependenceTarget long-lead bookings with reminders, waitlist fills, or navigation
Authorization denials appear concentrated at one hospitalDenial-reason distributions are equal across sitesHomogeneityInvestigate site-specific registration, authorization, and documentation workflows

Common Design Error

The ordinary chi-square test assumes independent observations. If the same patient, clinician, unit, or hospital contributes repeated observations, the nominal p-value may be too small because the effective information is less than the row count suggests.

Pre-analysis data readiness

Statistical correctness begins before the contingency table is built. Operational databases are encounter-centered, longitudinal, and frequently revised. A leader should require a brief analytical specification covering unit of analysis, population, period, categories, denominator, exclusion rules, and the treatment of missing or repeated observations. Work through each control below and confirm it has an explicit answer.

0of 7 controls confirmed

A calculation should not proceed to executive interpretation until every control has an explicit answer.

Unit of analysis

Patient, appointment, claim, examination, event, or response?

Failure mode: mixing units creates invalid totals. Safeguard: state one unit in the analytic charter.

Mutual exclusivity

Can one observation occupy more than one category?

Failure mode: double-counting inflates sample size. Safeguard: use a hierarchy or one primary classification.

Exhaustiveness

Where do unknown, pending, and other observations go?

Failure mode: selective omission changes proportions. Safeguard: report missing and unclassified counts.

Independence

Can the same patient or site contribute repeated observations?

Failure mode: standard errors are understated. Safeguard: deduplicate, aggregate, or use clustered methods.

Expected counts

Are cells sufficiently populated for the approximation?

Failure mode: p-values can be inaccurate. Safeguard: use exact or simulation-based alternatives.

Stable definitions

Did codes or workflows change during the period?

Failure mode: apparent differences reflect taxonomy drift. Safeguard: version categories and document change dates.

Denominator

Are percentages based on comparable opportunities?

Failure mode: counts obscure exposure differences. Safeguard: report both counts and relevant rates.

Expected-count guidance

The familiar statement that every cell must contain at least five observations is an oversimplification. The issue concerns expected counts and the adequacy of the asymptotic approximation. A common practical rule: no expected count below 1, and no more than approximately 20% below 5. For sparse 2-by-2 tables, Fisher’s exact test or other exact procedures should be considered; simulation evidence also shows that default continuity corrections are not universally optimal (Campbell, 2007; Kim, 2017; Lydersen et al., 2009).

Missing data

Missing categories should be quantified rather than silently dropped. Report unknown and unclassified counts alongside the analytic table so proportions remain interpretable.

Category collapse

Categories may be combined only when the new grouping is substantively coherent and prespecified. Collapsing categories to obtain a desired p-value changes the question and compromises interpretability.

Goodness of fit Worked healthcare case 1 · Illustrative synthetic data

Does CT demand match the staffing plan?

A hospital planned CT staffing around a 40% day, 40% evening, and 20% night demand distribution. During an illustrative month, 600 examinations were completed. Shift is compared with a distribution specified before the observations were analyzed, so this is a goodness-of-fit question.

7.50χ² statistic (df = 2)
.024p-value
.112Cohen’s w (small)
±30Exam shift, day to evening

Observed CT volume compared with the staffing plan distribution. The overall difference is statistically detectable, but the pattern is operationally concentrated in a 30-examination shift from day to evening.

ShiftObservedExpectedO − ECell contribution
Day210240−303.75
Evening270240+303.75
Night12012000.00
Total60060007.50

The statistical evidence challenges exact alignment with the staffing distribution, but the magnitude is small. The operationally relevant fact is that evening demand exceeded plan by 30 examinations while day demand was 30 below plan. A leader should examine complexity-weighted workload, turnaround time, overtime, and arrival sources before moving staff. Counts alone do not establish the number or skill mix of resources required.

Decision Translation

Do not respond to p = .024 by automatically adding evening staff. First determine whether the 30-examination variance is persistent, whether it affects turnaround or safety, and whether demand can be shifted through scheduling design. Then test a staffing or template intervention with balancing measures.

Test of independence Worked healthcare case 2 · Illustrative synthetic data

Is imaging nonattendance associated with scheduling lead time?

Missed imaging appointments delay diagnosis, reduce asset utilization, and waste specialized labor. Among 720 scheduled outpatient imaging appointments, is completion status associated with the time between scheduling and the appointment? Under the null hypothesis of independence, every lead-time row would hold 160 completed and 20 missed appointments because all four row totals are equal.

40.61χ² statistic (df = 3)
< .001p-value
.238Cramer’s V
6.8×Missed-rate ratio, 15+ vs 0-3 days
Lead timeCompletedMissedTotalMissed rate
0-3 days17461803.3%
4-7 days169111806.1%
8-14 days1582218012.2%
15+ days1394118022.8%
Total6408072011.1%

Missed appointment rates rise monotonically from 3.3% to 22.8% across lead-time categories.

The 15+ day category accounts for 24.81 of the total 40.61 statistic, approximately 61%. A global p-value alone would conceal this operational localization.

Which cells drive the result?

Adjusted standardized residuals localize the association. Values approximate z-scores under the null model: positive means more observations than expected, negative means fewer.

−3.83Missed at 0-3 days: far fewer than expected
−2.46Missed at 4-7 days: fewer than expected
+0.55Missed at 8-14 days: near expectation
+5.75Missed at 15+ days: far more than expected

Leadership interpretation

The long-lead group shows approximately 6.8 times the observed missed-appointment rate of the 0-3 day group. That ratio is descriptive and unadjusted. The next analysis should use logistic regression or a related model to account for modality, prior missed visits, age, insurance, socioeconomic context, referral source, day of week, and repeated appointments. Operational action may include waitlist automation, confirmation escalation, transportation screening, patient navigation, or reserved short-lead capacity. Interventions should be designed to avoid labeling patients as noncompliant when the underlying constraint is structural access.

Executive Reporting Language

Appointment completion was associated with scheduling lead time, χ²(3, N = 720) = 40.61, p < .001, Cramer’s V = .24. Adjusted residuals localized excess missed appointments to the 15+ day group. Because the analysis is unadjusted and encounter-based, the findings should guide targeted investigation and prospective testing rather than causal attribution.

Test of homogeneity Worked healthcare case 3 · Illustrative synthetic data

Are denial-reason distributions homogeneous across hospitals?

Three hospitals each recorded 200 denied claims. Is the distribution of denial reasons the same across sites, or do particular hospitals show distinctive patterns requiring site-specific intervention? Aggregate denial rates can conceal distinct causal structures across sites.

26.90χ² statistic (df = 8)
< .001p-value
.150Cramer’s V (modest)
600Denied claims analyzed

Observed denial reasons across three hospital sites, 200 denied claims per site. With equal site totals, each row expects 41.67 eligibility, 50 authorization, 43.33 medical-necessity, 45 coding and documentation, and 20 other denials.

Adjusted residuals reveal where distributions diverge

Residual magnitudes near or above 2 identify cells that differ materially from the null model. Positive values indicate more denials than expected, negative values fewer.

North shows substantially more authorization denials than expected and fewer eligibility denials. South shows the opposite pattern. Central displays no equally dominant deviation. A systemwide intervention aimed at only one denial reason would be inefficient.

Translating residuals into targeted revenue-cycle action

Site signalOperational hypothesisValidationPotential intervention
North: authorization excessScheduling or authorization workflow is incomplete or lateAudit lead time, payer rules, order completeness, and handoffsAuthorization work queue, escalation standard, pre-service checklist
South: eligibility excessCoverage verification or registration data are unreliableAudit eligibility response, demographics, plan changes, and registration reworkReal-time eligibility, registrar feedback, hard stops for missing fields
Central: diffuse patternNo single reason dominatesReview severity, payer mix, appeal yield, and low-frequency subcategoriesMaintain broad controls and monitor for emerging concentration

Leadership Conclusion

The test supports differentiated intervention. North requires an authorization-centered investigation, South requires an eligibility-centered investigation, and Central requires broader monitoring. The effect size indicates that site is informative but not determinative; payer and service-line stratification remain important.

Live chi-square calculator

Run the full decision-ready computation on your own counts: statistic, degrees of freedom, exact p-value, effect size, expected counts, adjusted residuals, and an expected-count adequacy screen. The engine reproduces every result in the three worked cases. Illustrative use only; validate against local data and governance review before operational decisions.

Compare observed counts with expected percentages specified in advance. Preloaded with Case 1, CT demand by shift.

Validation Control

Reproduce at least one small table by hand or in a second validated tool. Confirm the same N, expected counts, chi-square, degrees of freedom, p-value, and effect size before presenting the result.

Interpretation beyond the p-value

Healthcare leaders should reject the false choice between statistical rigor and practical relevance. Both are required. A p-value assesses compatibility with the null model, while effect size and operational consequences address magnitude and decision value. Large datasets can make small discrepancies statistically detectable; small datasets can conceal operationally important differences through low power.

Cramer’s V

V = √[χ² / (N × min(r − 1, c − 1))]

Ranges 0 to 1 and standardizes association strength for contingency tables. For 2-by-2 tables, phi is common; for goodness-of-fit, use Cohen’s w.

Pearson residual

r = (O − E) / √E

Adjusted standardized residuals also account for marginal proportions and are preferable for localizing unusual cells.

Cohen’s w

w = √[Σ(pobs − pexp)² / pexp]

Goodness-of-fit effect size computed on proportions rather than counts.

Four layers of a decision-ready interpretation

1

Statistical

Is the observed table unusual under the null model? Requires chi-square, df, p-value, and assumption checks.

2

Magnitude

How strong is the discrepancy or association? Requires Cramer’s V, phi, or Cohen’s w plus absolute percentage differences.

3

Diagnostic

Which cells or categories drive the result? Requires observed and expected counts, adjusted residuals, and planned follow-up.

4

Operational

What should change, who owns it, and what could be harmed? Requires process knowledge, cost, patient impact, feasibility, and balancing measures.

Sample size and power planning

Approximate N required for df = 3, alpha = .05, and 80% power. Required N grows rapidly as the target effect becomes smaller; real studies require category-specific planning.

A nonsignificant result may mean either that the null model is reasonably compatible with the data or that the study lacks power to detect the effect that matters. Sample-size planning should begin with the smallest operationally important effect, the intended degrees of freedom, alpha, power, expected category proportions, and the feasibility of adequate cell counts (Rahman et al., 2025). Unequal marginal distributions, sparse categories, multiple comparisons, clustering, and attrition all increase the required sample. Leaders should also avoid collecting an enormous sample merely to declare a trivial difference significant.

Planning Rule

Define the minimum difference that would change an operational decision. Power the study to detect that difference, then confirm that each planned category will have sufficient expected observations. If the minimum actionable difference is not defined, the sample-size calculation is not decision anchored.

When the ordinary chi-square is not the best primary method

Data situationWhy ordinary chi-square is insufficientPreferred direction
Sparse 2-by-2 tableAsymptotic p-value may be inaccurateFisher’s exact or another exact or unconditional test
Same patients before and afterBinary outcomes are paired, not independentMcNemar’s test; conditional or mixed modeling
More than two repeated binary measurementsWithin-person correlationCochran’s Q, GEE, or mixed-effects model
Ordered exposure or outcomeOmnibus chi-square ignores monotonic trendCochran-Armitage trend test or ordinal and logistic regression
Need to adjust for case mixBivariate association may be confoundedBinary, multinomial, or ordinal logistic regression
Counts with unequal exposure timeRaw counts are not comparable to ratesPoisson or negative-binomial regression with offset
Patients nested in clinicians or hospitalsCluster correlation understates uncertaintyCluster-robust, GEE, or multilevel model
Monthly performance monitoringRepeated significance tests ignore temporal structureStatistical process control, interrupted time series, or longitudinal model

For 2-by-2 tables, methodological research shows that test choice is more nuanced than the simplistic rule of using Fisher when n is small. The sampling scheme, desired error properties, expected counts, and availability of exact unconditional or mid-p procedures all matter (Campbell, 2007; Lydersen et al., 2009). Consultation with a statistician is appropriate when events are rare, tables are sparse, or the analysis will inform high-stakes clinical or financial policy.

The healthcare leader’s operating cycle

A chi-square analysis should be embedded in an operating cycle that connects measurement to intervention. The cycle begins with the decision and ends with re-measurement, because a one-time significance test does not establish sustained improvement.

1Frame2Validate3Test4Diagnose5Act6Re-measure

1 · Frame

State the decision, unit of analysis, population, categories, expected pattern, and action threshold.

2 · Validate

Confirm source systems, duplicate handling, missingness, category stability, independence, denominators, and expected counts.

3 · Test

Calculate the appropriate statistic, degrees of freedom, p-value, and effect size with reproducible code or validated software.

4 · Diagnose

Compare observed and expected counts; inspect adjusted residuals; apply planned post hoc controls; stratify where process knowledge warrants.

5 · Act

Translate the localized signal into a workflow hypothesis, owner, intervention, implementation date, and balancing measures.

6 · Re-measure

Use an appropriate post-change design. For ongoing monthly monitoring, supplement testing with statistical process control or longitudinal methods.

Leadership review questions

Check off each question your team can answer before authorizing action on a chi-square result.

0 of 9 answered

Minimum reporting elements

ElementMinimum contentWhy leaders need it
Question and designPopulation, period, unit, variables, and selected chi-square typeConfirms that the method matches the decision
Observed dataCounts plus row or column percentagesShows the actual operational pattern and denominator
Expected dataExpected counts and adequacy checkDemonstrates that the approximation is defensible
Test resultChi-square, df, N, exact p-value or p < .001Quantifies evidence against the null model
MagnitudeCramer’s V, phi, or Cohen’s w plus absolute differencesSeparates detectable from important
LocalizationAdjusted residuals and controlled post hoc comparisonsIdentifies actionable categories
LimitationsMissingness, repeats, confounding, sparse cells, multiple testing, generalizabilityPrevents overclaiming
ActionOwner, intervention, timeline, outcome, and balancing measuresConverts analysis into accountable improvement

Governance, equity, and ethical interpretation

Categorical analyses can identify disparities, but they can also reproduce biased classification, missingness, and structural differences in access. A significant association between a patient characteristic and nonattendance should not be interpreted as an individual deficit. It may reflect transportation, work schedules, digital access, language, caregiving obligations, referral design, or the location and timing of services (Cleary et al., 2024; Mander et al., 2018).

Governance safeguards

  • Use the minimum necessary data and de-identify operational extracts whenever feasible
  • Review small cells for privacy risk as well as statistical instability
  • Document category definitions, mappings, and changes in the data dictionary
  • Require independent analytic review when results will influence high-stakes clinical, employment, or financial policy

Equity practices

  • Avoid using protected characteristics as simplistic causal explanations or punitive targeting variables
  • Include patient and frontline perspectives when translating an association into an intervention
  • Measure whether the intervention changes access, experience, or burden differently across groups

Equity Principle

The operational goal is to redesign barriers, not to classify patients as the problem. Chi-square can reveal where categorical outcomes differ, but leadership must investigate the system that produces those differences.

Final Leadership Takeaway

Use chi-square to detect and localize categorical operational variation. Use process knowledge, effect size, adjusted analysis, and patient-centered judgment to decide what that variation means and what should change.

References

APA 7th edition. DOI links are provided for verification and access. Filter by domain.

Campbell, I. (2007). Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Statistics in Medicine, 26(19), 3661-3675.

doi.org/10.1002/sim.2832

Chandawarkar, R., Nadkarni, P., Barmash, E., Thomas, S., Capek, A., Casey, K., & Carradero, F. (2024). Revenue cycle management: The art and the science. Plastic and Reconstructive Surgery – Global Open, 12(7), e5756.

doi.org/10.1097/GOX.0000000000005756

Cleary, M., Edwards, C., Mitchell-Watson, J., Yang, J., & Reddan, T. (2024). Benchmarking non-attendance patterns in pediatric medical imaging: A retrospective cohort study spotlighting First Nations children. Radiography, 30(2), 492-499.

doi.org/10.1016/j.radi.2024.01.002

Dantas, L. F., Fleck, J. L., Oliveira, F. L. C., & Hamacher, S. (2018). No-shows in appointment scheduling: A systematic literature review. Health Policy, 122(4), 412-421.

doi.org/10.1016/j.healthpol.2018.02.002

Franke, T. M., Ho, T., & Christie, C. A. (2012). The chi-square test: Often used and more often misinterpreted. American Journal of Evaluation, 33(3), 448-458.

doi.org/10.1177/1098214011426594

Greenland, S., Senn, S. J., Rothman, K. J., Carlin, J. B., Poole, C., Goodman, S. N., & Altman, D. G. (2016). Statistical tests, P values, confidence intervals, and power: A guide to misinterpretations. European Journal of Epidemiology, 31(4), 337-350.

doi.org/10.1007/s10654-016-0149-3

Hess, A. S., & Hess, J. R. (2017). Understanding tests of the association of categorical variables: The Pearson chi-square test and Fisher’s exact test. Transfusion, 57(4), 877-879.

doi.org/10.1111/trf.14057

Kim, H. Y. (2017). Statistical notes for clinical researchers: Chi-squared test and Fisher’s exact test. Restorative Dentistry & Endodontics, 42(2), 152-155.

doi.org/10.5395/rde.2017.42.2.152

Kovach, J. V., & Borikar, S. (2018). Enhancing financial performance: An application of Lean Six Sigma to reduce insurance claim denials. Quality Management in Health Care, 27(3), 165-171.

doi.org/10.1097/QMH.0000000000000175

Lang, T. A., & Altman, D. G. (2015). Basic statistical reporting for articles published in biomedical journals: The SAMPL guidelines. International Journal of Nursing Studies, 52(1), 5-9.

doi.org/10.1016/j.ijnurstu.2014.09.006

Lydersen, S., Fagerland, M. W., & Laake, P. (2009). Recommended tests for association in 2 x 2 tables. Statistics in Medicine, 28(7), 1159-1175.

doi.org/10.1002/sim.3531

Mander, G. T. W., Reynolds, L., Cook, A., & Kwan, M. M. (2018). Factors associated with appointment non-attendance at a medical imaging department in regional Australia: A retrospective cohort analysis. Journal of Medical Radiation Sciences, 65(3), 192-199.

doi.org/10.1002/jmrs.284

McHugh, M. L. (2013). The chi-square test of independence. Biochemia Medica, 23(2), 143-149.

doi.org/10.11613/BM.2013.018

Mohammadi, I., Wu, H., Turkcan, A., Toscos, T., & Doebbeling, B. N. (2018). Data analytics and modeling for appointment no-show in community health centers. Journal of Primary Care & Community Health, 9, 1-11.

doi.org/10.1177/2150132718811692

Norbash, A., Yucel, K., Yuh, W., Doros, G., Ajam, A., Lang, E. V., Pauker, S., & Mayr, N. (2016). Effect of team training on improving MRI study completion rates and no-show rates. Journal of Magnetic Resonance Imaging, 44(4), 1040-1047.

doi.org/10.1002/jmri.25219

Pearson, K. (1900). On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science, 50(302), 157-175.

doi.org/10.1080/14786440009463897

Rahman, H. A., Noraidi, A. A., Khalid, A. N. H., Mohamad-Adam, A. Z., Zahari, N. H., & Tuming, N. E. (2025). Practical guide to calculate sample size for chi-square test in biomedical research. BMC Medical Research Methodology, 25, 144.

doi.org/10.1186/s12874-025-02584-4

Sharpe, D. (2015). Your chi-square test is statistically significant: Now what? Practical Assessment, Research & Evaluation, 20(8), 1-10.

doi.org/10.7275/tbfa-x148

Sullivan, G. M., & Feinn, R. (2012). Using effect size, or why the P value is not enough. Journal of Graduate Medical Education, 4(3), 279-282.

doi.org/10.4300/JGME-D-12-00156.1

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. PLoS Medicine, 4(10), e296.

doi.org/10.1371/journal.pmed.0040296

Wasserstein, R. L., & Lazar, N. A. (2016). The ASA’s statement on p-values: Context, process, and purpose. The American Statistician, 70(2), 129-133.

doi.org/10.1080/00031305.2016.1154108

CrashCourse. (2018, August 29). Chi-square tests: Crash Course Statistics #29 [Video]. YouTube.

youtube.com/watch?v=7_cs1YlZoug

Prepared as an executive research and education resource by Kelly Emrick, DHSc, PhD, MBA, BSRT(ARRT)R. The statistical examples are synthetic and should not be used for patient-care, staffing, or financial decisions without validation against local data, governance review, and appropriate statistical consultation.